O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+11.18%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$9.5B
AUM Growth
+$9.5B
(+8.1%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
1.57%
Top 10 Holdings %
Top 10 Hldgs %
34.99%
Holding
144
New
11
Increased
35
Reduced
32
Closed
10
Top Buys
| 1 |
Cigna
CI
|
$205M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$197M |
| 3 |
Gilead Sciences
GILD
|
$90.1M |
| 4 |
Viatris
VTRS
|
$65.2M |
| 5 |
Biogen
BIIB
|
$52.4M |
Top Sells
| 1 |
Centene
CNC
|
$118M |
| 2 |
HCA Healthcare
HCA
|
$100M |
| 3 |
Pfizer
PFE
|
$99M |
| 4 |
Tenet Healthcare
THC
|
$94.8M |
| 5 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$74.8M |
Sector Composition
| 1 | Healthcare | 92.98% |
| 2 | Financials | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Integra LifeSciences
IART
$1.18B
| $23.3M | 0.24% | +426,910 | New | +$23.3M |
|
|
OBSV
77
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $22.3M | 0.23% | 2,605,531 | – | – |
|
78
Galapagos
GLPG
$2.07B
| $21.7M | 0.23% | 283,500 | – | – |
|
79
Assembly Biosciences
ASMB
$190M
| $18.3M | 0.19% | 888,426 -368,874 | -29% | -$7.62M |
|
|
DBVT
80
DBV Technologies
DBVT
$264M
| $18.3M | 0.19% | 512,900 | – | – |
|
|
SVA
81
DELISTED
Sinovac Biotech, Ltd
SVA
| $18M | 0.19% | 2,667,500 | – | – |
|
82
Teva Pharmaceuticals
TEVA
$21.1B
| $17.5M | 0.18% | 526,300 +113,700 | +28% | +$3.78M |
|
|
CTIC
83
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $16.6M | 0.17% | +5,000,000 | New | +$16.6M |
|
84
Vanda Pharmaceuticals
VNDA
$279M
| $15.8M | 0.17% | 967,859 +917,659 | +1,828% | +$15M |
|
85
Xencor
XNCR
$580M
| $15.8M | 0.17% | 747,244 -92,993 | -11% | -$1.96M |
|
86
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $15.5M | 0.16% | 1,079,700 -4,700 | -0.4% | -$67.4K |
|
87
Eledon Pharmaceuticals
ELDN
$155M
| $14.8M | 0.16% | +2,537,110 | New | +$14.8M |
|
88
Natera
NTRA
$23.1B
| $13.9M | 0.15% | 1,276,190 | – | – |
|
|
LUMO
89
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $13.6M | 0.14% | 1,846,000 -145,700 | -7% | -$1.07M |
|
90
Neurocrine Biosciences
NBIX
$13.8B
| $13.1M | 0.14% | 284,841 -156,500 | -35% | -$7.2M |
|
|
WMGIZ
91
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
| $12.7M | 0.13% | 8,679,975 +1,779,975 | +26% | +$2.6M |
|
92
ProQR Therapeutics
PRQR
$237M
| $12M | 0.13% | 2,305,446 | – | – |
|
93
Aurinia Pharmaceuticals
AUPH
$1.58B
| $11M | 0.12% | 1,797,400 | – | – |
|
94
argenx
ARGX
$43.6B
| $10.6M | 0.11% | +500,000 | New | +$10.6M |
|
95
Heron Therapeutics
HRTX
$207M
| $9M | 0.09% | 650,000 | – | – |
|
|
ADAP
96
Adaptimmune Therapeutics
ADAP
$15.6M
| $8.6M | 0.09% | 1,914,660 | – | – |
|
97
Alkermes
ALKS
$4.78B
| $8.41M | 0.09% | 145,000 | – | – |
|
|
DMTX
98
DELISTED
Dimension Therapeutics, Inc
DMTX
| $7.83M | 0.08% | 5,397,698 | – | – |
|
|
VRNA
99
Verona Pharma
VRNA
$9.16B
| $7.77M | 0.08% | +666,666 | New | +$7.77M |
|
100
Standard BioTools
LAB
$481M
| $7.05M | 0.07% | 1,746,100 | – | – |
|